CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer.
- Published in:
- Cancer Gene Therapy, 2015, v. 22, n. 11, p. 509, doi. 10.1038/cgt.2015.54
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2015 AND VI 22 AND IP 11
Results: 6
1
2
Conditioned media from human ovarian cancer endothelial progenitor cells induces ovarian cancer cell migration by activating epithelial-to-mesenchymal transition.
- Published in:
- Cancer Gene Therapy, 2015, v. 22, n. 11, p. 518, doi. 10.1038/cgt.2015.45
- By:
- Publication type:
- Article
3
Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells.
- Published in:
- Cancer Gene Therapy, 2015, v. 22, n. 11, p. 536, doi. 10.1038/cgt.2015.52
- By:
- Publication type:
- Article
4
Efficient expression of bioactive murine IL12 as a self-processing P2A polypeptide driven by inflammation-regulated promoters in tumor cell lines.
- Published in:
- Cancer Gene Therapy, 2015, v. 22, n. 11, p. 542, doi. 10.1038/cgt.2015.53
- By:
- Publication type:
- Article
5
Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma.
- Published in:
- Cancer Gene Therapy, 2015, v. 22, n. 11, p. 530, doi. 10.1038/cgt.2015.51
- By:
- Publication type:
- Article
6
Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
- Published in:
- Cancer Gene Therapy, 2015, v. 22, n. 11, p. 524, doi. 10.1038/cgt.2015.48
- By:
- Publication type:
- Article